Harmen Beurmanjer

114 References van Amsterdam, J., Brunt, T., Pennings, E., & van den Brink, W. (2015). Risk assessment of GBL as a substitute for the illicit drug GHB in the Netherlands. A comparison of the risks of GBL versus GHB. Regulatory Toxicology and Pharmacology , 70 (2), 507–513. https://doi.org/10.1016/j.yrtph.2014.08.014 van Amsterdam, J. G. C., van Laar, M., Brunt, T. M., & van den Brink, W. (2012). Risk assessment of gamma-hydroxybu- tyric acid (GHB) in the Netherlands. Regulatory Toxicology and Pharmacology . https://doi.org/10.1016/j. yrtph.2012.03.005 Van Boekel, L. C., Brouwers, E. P. M., Van Weeghel, J., & Garretsen, H. F. L. (2013). Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review. Drug and Alcohol Dependence . https://doi.org/10.1016/j.drugalcdep.2013.02.018 Van Noorden, M., Kamal, R., Dijkstra, B., Brunt, T. M., & De Jong, C. (2016). Gamma-Hydroxybutyrate Abuse and Dependence. In Neuropathology of Drug Addictions and Substance Misuse (Vol. 2, pp. 379–387). https://doi. org/10.1016/B978-0-12-800212-4.00036-4 van Noorden, M. S., Kamal, R. M., Dijkstra, B. A. G., Mauritz, R., & de Jong, C. A. J. (2015). A Case Series of Pharmaceutical Gamma-Hydroxybutyrate in 3 Patients With Severe Benzodiazepine-Resistant Gamma-Hydroxybutyrate Withdrawal in the Hospital. Psychosomatics , 56 (4), 404–409. https://doi.org/10.1016/j.psym.2014.03.002 van Noorden, M. S., Mol, T., Wisselink, J., Kuijpers, W., & Dijkstra, B. A. G. (2017). Treatment consumption and treatment re-enrollment in GHB-dependent patients in The Netherlands. Drug and Alcohol Dependence , 176 , 96–101. https://doi.org/10.1016/j.drugalcdep.2017.02.026 van Noorden, M. S., van Dongen, L. C. A. M., Zitman, F. G., & Vergouwen, T. (A )C M. (2009). Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known. General Hospital Psychiatry , 31 (4), 394–396. https://doi. org/10.1016/j.genhosppsych.2008.11.001 Verdejo-Garcia, A. (2016). Cognitive training for substance use disorders: Neuroscientific mechanisms. Neuroscience and Biobehavioral Reviews . https://doi.org/10.1016/j.neubiorev.2016.05.018 Verdejo-Garcia, A., Garcia-Fernandez, G., & Dom, G. (2019). Cognition and addiction. Dialogues inClinical Neuroscience . https://doi.org/10.31887/DCNS.2019.21.3/gdom Volkow, N. D., Koob, G. F., &McLellan, A. T. (2016). Neurobiologic Advances from the Brain Disease Model of Addiction. New England Journal of Medicine , 374 (4), 363–371. https://doi.org/10.1056/NEJMra1511480 Volkow, N. D., & Morales, M. (2015). The Brain on Drugs: From Reward to Addiction. Cell . https://doi.org/10.1016/j. cell.2015.07.046 Vorspan, F., Mehtelli, W., Dupuy, G., Bloch, V., & Lépine, J. P. (2015). Anxiety and Substance UseDisorders: Co-occurrence and Clinical Issues. Current Psychiatry Reports . https://doi.org/10.1007/s11920-014-0544-y Walvoort, S. J. W., Wester, A. J., Doorakkers, M. C., Kessels, R. P. C., & Egger, J. I. M. (2016). Alcohol-related cognitive impairment and the DSM-5. Tijdschrift Voor Psychiatrie , 58 (5), 397–401. Wobrock, T., Falkai, P., Schneider-Axmann, T., Frommann, N., Wölwer, W., & Gaebel, W. (2009). Effects of abstinence on brain morphology in alcoholism : AAA MRI study. European Archives of Psychiatry and Clinical Neuroscience . https://doi.org/10.1007/s00406-008-0846-3 Wong, C. G. T., Chan, K. F. Y., Gibson, K. M., & Snead, O. C. (2004). γ-Hydroxybutyric acid: Neurobiology and toxicology of a recreational drug. Toxicological Reviews , Vol. 23, pp. 3–20. https://doi.org/10.2165/00139709-200423010-00002 Xie, X., & Smart, T. G. (1992). γ-Hydroxybutyrate hyperpolarizes hippocampal neurones by activating GABAB receptors. European Journal of Pharmacology , 212 (2–3), 291–294. https://doi.org/10.1016/0014-2999( 92)90347-7 Zaal, I. J., Devlin, J. W., Hazelbag, M., Klein Klouwenberg, P. M. C., van der Kooi, A. W., Ong, D. S. Y., … Slooter, A. J. C. (2015). Benzodiazepine-associateddeliriumin critically ill adults. IntensiveCareMedicine . https://doi.org/10.1007/ s00134-015-4063-z